Integrative mapping of the dog epigenome: Reference annotation for comparative intertissue and cross-species studies

Dogs have become a valuable model in exploring multifaceted diseases and biology relevant to human health. Despite large-scale dog genome projects producing high-quality draft references, a comprehensive annotation of functional elements is still lacking. We addressed this through integrative next-g...

Full description

Saved in:
Bibliographic Details
Published inScience advances Vol. 9; no. 27; p. eade3399
Main Authors Son, Keun Hong, Aldonza, Mark Borris D, Nam, A-Reum, Lee, Kang-Hoon, Lee, Jeong-Woon, Shin, Kyung-Ju, Kang, Keunsoo, Cho, Je-Yoel
Format Journal Article
LanguageEnglish
Published United States American Association for the Advancement of Science 07.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dogs have become a valuable model in exploring multifaceted diseases and biology relevant to human health. Despite large-scale dog genome projects producing high-quality draft references, a comprehensive annotation of functional elements is still lacking. We addressed this through integrative next-generation sequencing of transcriptomes paired with five histone marks and DNA methylome profiling across 11 tissue types, deciphering the dog's epigenetic code by defining distinct chromatin states, super-enhancer, and methylome landscapes, and thus showed that these regions are associated with a wide range of biological functions and cell/tissue identity. In addition, we confirmed that the phenotype-associated variants are enriched in tissue-specific regulatory regions and, therefore, the tissue of origin of the variants can be traced. Ultimately, we delineated conserved and dynamic epigenomic changes at the tissue- and species-specific resolutions. Our study provides an epigenomic blueprint of the dog that can be used for comparative biology and medical research.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: GeneOne Life Science Inc., Seoul, Korea.
These authors contributed equally to this work.
Present address: Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.ade3399